mda-mb-468 glutathione content Using a novel panel of drug-resistant triple-negative breast cancer cell lines to identify candidate therapeutic targets and biomarkers MDA-MB-468 - AcceGen
MDA MB 468 AcceGen Frontiers Formononetin triggers ferroptosis in triple negative breast cancer cells by regulating the mTORC1 SREBP1 SCD1 pathway Anticancer Effects of Thymoquinone through the Antioxidant Activity, Upregulation of Nrf2, and Downregulation of PD L1 in Triple Negative Breast Cancer Cells Gankyrin inhibits ferroptosis through the p53 SLC7A11 GPX4 axis in triple negative breast cancer cells Scientific Reports Cell lines MDA MB 468, MDA MB 231 and HCC38 show sensitivity to Download Scientific Diagram Natural product preferentially targets redox and metabolic adaptations and aberrantly active STAT3 to inhibit breast tumor growth in vivo Cell Death & Disease
Pay in 4 interest-free payments of $7.05 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6





